AIHW logo
METEOR logo
Our sites
AIHW GEN Aged Care Data Aboriginal and Torres Strait Islander
Health Performance Framework
Indigenous Mental Health and
Suicide Prevention Clearinghouse
Australian Mesothelioma Registry Housing data Regional Insights for Indigenous Communities
Contact FAQs
  • Find metadata
    • Find metadata
    • Getting started
    • Data set specifications
    • Indicator sets
    • Data quality statements
    • Data dictionary archives
  • Metadata management
    • Metadata management
    • Data standards
    • Registration authorities
    • Registration statuses
  • How to use METEOR
    • How to use METEOR
    • First steps
    • Using My Page
    • Downloading and printing
    • FAQs
    • About METEOR
  • Learn about metadata
    • Learn about metadata
    • Metadata explained
    • How to create metadata
    • Metadata development resources

Person—dyslipidaemia treatment with anti-lipid medication indicator (current), code N

Identifying and definitional attributes

Metadata item type:Help on this termData Element
Short name:Help on this termDyslipidaemia treatment indicator
METEOR identifier:Help on this term302440
Registration status:Help on this term
  • Health, Standard 21/09/2005
Definition:Help on this term

Whether a person is being currently treated for dyslipidaemia using anti-lipid medication, as represented by a code.

Data Element Concept:Person—dyslipidaemia treatment with anti-lipid medication indicator

Value domain attributes

Representational attributes

Representation class:Help on this termCode
Data type:Help on this termNumber
Format:Help on this termN
Maximum character length:Help on this term1
Permissible values:Help on this term
ValueMeaning
1Yes
2No
Supplementary values:Help on this term
ValueMeaning
9Not stated/inadequately described

Collection and usage attributes

Guide for use:Help on this term

CODE 9    Not stated/inadequately described

This code is not for use in primary data collections.

Data element attributes

Collection and usage attributes

Guide for use:Help on this term

CODE 1   Yes
Record if a person is being treated for dyslipidaemia using anti-lipid medication.

CODE 2   No
Record if a person is not being treated for dyslipidaemia using anti-lipid medication.

Collection methods:Help on this term

Ask the individual if he/she is currently treated with anti-lipid medication. Alternatively obtain the relevant information from appropriate documentation.

Source and reference attributes

Submitting organisation:Help on this term

National diabetes data working group

Origin:Help on this term

National Diabetes Outcomes Quality Review Initiative (NDOQRIN) data dictionary.

Relational attributes

Related metadata references:Help on this term
Supersedes Person—dyslipidaemia treatment status (anti-lipid medication), code N
  • Health, Superseded 21/09/2005
Implementation in Data Set Specifications:Help on this term
All attributes +

Acute coronary syndrome (clinical) DSSHealth, Superseded 01/09/2012

Acute coronary syndrome (clinical) DSSHealth, Superseded 02/05/2013

Acute coronary syndrome (clinical) NBPDS Health, Recorded 15/05/2017

Acute coronary syndrome (clinical) NBPDS 2013-Health, Standard 02/05/2013

DSS specific attributes +

Implementation start date: 01/07/2013


Diabetes (clinical) NBPDSHealth, Standard 21/09/2005

DSS specific attributes +

DSS specific information:

Dyslipidaemia is associated with many health problems including diabetes and hypertension. It is often related to overweight and obesity. Usually caused by inappropriate diet and sedentary lifestyle, dyslipidaemia has been reaching epidemic proportions. Active lifestyle and low calorie diets are the best way of prevention, however sometimes for the treatment of dyslipidaemia the use of pharmacotherapy is required. Abnormal levels of blood lipids are associated with increased risk of developing CHD especially in diabetic patients.

The risk of coronary and other macrovascular disorders is 2-5 times higher in people with diabetes than in non-diabetic subjects and increases in parallel with the degree of dyslipidaemia. Diabetes mellitus greatly modifies the significance of lipoprotein levels, particularly when associated with smoking, hypertension and family history of CVD. Poor metabolic control of diabetes seems to have impact on abnormal lipoprotein level. Primary dyslipidaemia, due to genetic and environmental (especially dietary) factors, is diagnosed if secondary causes have been excluded (hypothyroidism, nephrotic syndrome, cholestasis, anorexia nervosa, diabetes mellitus Type 2, renal impairment).


Help
Downloading

The download may take a while, please wait.

Do not refresh the screen until the download is complete.

<Title>

<body>
<footer>
  • View
  • Show more
  • Print view
  • Download
  • Word™
  • Pdf
  • Advanced Download
  • Review
  • Compare items
© Australian Institute of Health and Welfare
Version 1.0.0+20220531.2